Medline Stock Forecast

Stock Price Forecast

The 23 analysts that cover Medline stock have a consensus rating of "Strong Buy" and an average price target of $50.48, which forecasts a 5.96% increase in the stock price over the next year. The lowest target is $40 and the highest is $60.

Price Target: $50.48 (+5.96%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$40	$50.48	$50	$60
Change	-16.04%	+5.96%	+4.95%	+25.94%

* Price targets were last updated on Mar 11, 2026.

Analyst Ratings

The average analyst rating for Medline stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	7	8	8	8
Buy	12	12	12	12
Hold	3	3	3	3
Sell	0	0	0	0
Strong Sell	0	0	0	0
Total	22	23	23	23

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Patrick Donnelly Citigroup	Citigroup	Strong Buy Initiates $60	Strong Buy	Initiates	$60	+25.94%	Mar 11, 2026
Lisa Gill JP Morgan	JP Morgan	Buy Maintains $50 → $53	Buy	Maintains	$50 → $53	+11.25%	Mar 10, 2026
Ivan Feinseth Tigress Financial	Tigress Financial	Strong Buy Maintains $55 → $60	Strong Buy	Maintains	$55 → $60	+25.94%	Mar 9, 2026
David Larsen BTIG	BTIG	Strong Buy Reiterates $55	Strong Buy	Reiterates	$55	+15.45%	Mar 9, 2026
Patrick Wood Morgan Stanley	Morgan Stanley	Buy Maintains $48 → $52	Buy	Maintains	$48 → $52	+9.15%	Mar 2, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

31.53B

from 28.43B

10.88%

from 28.43B

Revenue Next Year

33.95B

from 31.53B

7.69%

from 31.53B

EPS This Year

1.50

from 1.43

4.82%

from 1.43

EPS Next Year

1.69

from 1.50

13.01%

from 1.50

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028
Revenue	21.45B	23.23B	25.51B	28.43B	31.53B	33.95B	36.56B
Revenue Growth	-	8.31%	9.80%	11.47%	10.88%	7.69%	7.70%
EPS	-	0.01	0.07	1.43	1.50	1.69	1.92
EPS Growth	-	-	413.80%	1,982.77%	4.82%	13.01%	13.53%
Forward PE	-	-	-	-	31.76	28.11	24.76
No. Analysts	-	-	-	-	29	29	18

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	32.7B	35.6B
Avg	31.5B	33.9B
Low	30.1B	32.3B

Revenue Growth

Revenue Growth	2026	2027
High	14.9%	12.9%
Avg	10.9%	7.7%
Low	5.8%	2.4%

EPS Forecast

EPS	2026	2027
High	1.65	1.92
Avg	1.50	1.69
Low	1.36	1.53

EPS Growth

EPS Growth	2026	2027
High	15.2%	28.1%
Avg	4.8%	13.0%
Low	-4.8%	1.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.